Developing countries are being seen by drug companies as ideal outsource locations for R&D and clinical trials. Steve Rogerson examines the pros and cons.
View Features by Category
Changing Pharma IT with Biobank For years the pharmaceutical industry has placed the idea of shared data in the 'too hard' basket.
Eli Lilly's Vigilant Approach Lessons of vigilance and responsiveness are as vital to major pharma companies as they are to any other business.